Related Experiment Video
Updated: Apr 1, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
pH-Responsive Micelles as Theranostic Agents for Sonodynamic Therapy and MR Imaging of Liver Abscesses
Hong Zhang1,2, Zhichao Cao3, Huanyu Chen1
1The Fourth Affiliated Hospital of Anhui Medical University, Chaohu, Anhui 238000, China.
Abstract:
Pyogenic liver abscess (PLA) caused by Klebsiella pneumoniae(K. pneumoniae) remains challenging to treat due to the lesion microenvironment that fosters biofilm formation and compromises antibiotic efficacy. Herein, we develop pH-responsive PC7A micelles co-loaded with levofloxacin (LEV) and manganese porphyrin (MnTPP) for imaging-guided, microenvironment-triggered sonodynamic-antibiotic therapy. The micelles remain stable under physiological conditions but selectively disassemble in mildly acidic infection niches, enabling the on-demand release of therapeutic payloads. Upon ultrasound (US) exposure, MnTPP acts as an efficient sonosensitizer to generate reactive oxygen species for biofilm disruption, while its paramagnetic property concurrently enhances T1-weighted MRI for real-time lesion localization and longitudinal treatment monitoring. In vitro, this platform effectively inhibits biofilm formation and eradicates LEV-resistant K. pneumoniae while also suppressing the emergence of drug-resistant variants compared to monotherapy. In vivo, MRI-guided treatment in a murine Klebsiella pneumoniae-associated liver abscess (K. pneumoniae liver abscess, KLA) model significantly reduces intra-abscess bacterial burden and inflammatory markers while promoting hepatic tissue repair. By integrating microenvironment sensing, controlled release, SDT potentiation, and MRI navigation, this theranostic system addresses key challenges in managing deep-seated, drug-resistant infections and offers a promising precision strategy for KLA.
Insights
This study presents a novel micelle therapy for pyogenic liver abscesses caused by Klebsiella pneumoniae. The pH-responsive micelles deliver antibiotics and sonodynamic agents, improving treatment efficacy and enabling MRI monitoring.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Infectious Diseases
Background:
- Pyogenic liver abscesses (PLA) caused by Klebsiella pneumoniae (K. pneumoniae) present treatment challenges due to biofilm formation and reduced antibiotic efficacy.
- The infection microenvironment in PLA can hinder conventional therapeutic approaches.
Purpose of the Study:
- To develop a pH-responsive micelle system for targeted delivery of levofloxacin (antibiotic) and manganese porphyrin (sonosensitizer).
- To enable imaging-guided, microenvironment-triggered sonodynamic-antibiotic therapy for K. pneumoniae-associated liver abscesses (KLA).
Main Methods:
- Co-loading levofloxacin and manganese porphyrin into pH-responsive PC7A micelles.
- Utilizing ultrasound (US) for sonodynamic therapy (SDT) and MRI for lesion localization and monitoring.
- Evaluating the system's efficacy in vitro against K. pneumoniae biofilms and in vivo using a murine KLA model.
Main Results:
- Micelles selectively disassemble in acidic infection niches, releasing therapeutic payloads.
- MnTPP generates reactive oxygen species upon US exposure, disrupting biofilms and enhancing antibiotic action.
- In vivo studies demonstrated reduced bacterial burden, decreased inflammation, and promoted hepatic repair in MRI-guided treated mice.
Conclusions:
- The developed theranostic system integrates microenvironment sensing, controlled release, SDT, and MRI navigation.
- This approach offers a promising precision strategy for managing deep-seated, drug-resistant K. pneumoniae infections and KLA.
- The system effectively inhibits biofilm formation and eradicates LEV-resistant K. pneumoniae, suppressing resistance emergence.
More Related Videos
06:02Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
Published on: June 12, 2021
08:36Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012